Panel discussion as part of Krynica Forum 2024 with MedApp participation.

The panel discussion within Krynica Forum 2024 “European Entrepreneurial Region: how do Malopolska’s start-ups implement the innovative solutions of the future?” with the participation of Maciej Stanuch, CarnaLife Holo Technology Manager at MedApp S.A., is behind us.

CarnaLife Holo mixed reality 3D holographic imaging technology joins another hospital.

Doctors at the Bieganski Hospital in Lodz, Poland keep up with the times by using the latest medical technology to help patients. By using our software, doctors can better interpret patients’ diagnostic imaging data, which significantly contributes to improving the quality of treatment and reducing treatment time.

CarnaLife Holo’s real-time holographic cardiac echo imaging has been featured in the U.S. portal Cardiovascular Business.

A few months after receiving FDA certification, CarnaLife Holo has been spotlighted by the opinionated industry portal CardiovascularBusiness.com

MedApp S.A. reaches new standards: MDR Certification for CarnaLife Holo and CarnaLife System

CarnaLife Holo and CarnaLife System, have been awarded the prestigious MDR (Medical Device Regulation) certification.

The first treatments using CarnaLife Holo at the Silesian Medical University in Katowice, Poland.

On August 19, 2024, the first procedures using CarnaLife Holo mixed reality 3D holographic imaging technology were performed at the Clinic of the University Dental Center of the Silesian Medical University in Katowice.

MedApp’s CarnaLife Holo software will support a new specialty – stomatology.

As part of its new business segment, MedApp offers dentists advanced 3D/4D imaging technologies that can significantly improve the precision and efficiency of treatment.

MEDAPP S.A. joins the NVIDIA Developer Program to accelerate innovation in medical technology.

MEDAPP SA, a pioneering company in AR healthcare technology solutions, is excited to announce its recent membership in the NVIDIA Developer Program.

MedApp Looks to KPO Funds for Hospitals and Enters Dental Market

“We want to be one of the beneficiaries of the multi-billion dollar outlay from the KPO fund. We will gradually offer our CarnaLife Holo technology to more hospitals, so the domestic market remains very important to us.”

MedApp receives funding for innovative VR/AR project in healthcare.

On July 16, 2024, MedApp is pleased to announce the signing of a funding agreement for the project “We Are Health Champions – Disrupting the European Healthcare Systems with Virtual Reality and Augmented Reality Applications.”

MedApp S.A. launches a subsidiary in the U.S. and opens an office in Orlando!

We are pleased to announce the formation of a subsidiary MedApp USA Inc. headquartered in Dover, Delaware. The company’s operating office will be located in Orlando, Florida at the GuideWell Innovation Center, part of Medical City in Lake Nona.

MedApp at HIMSS24

We are very pleased to announce that MedApp SA will participate in one of the largest medical-technology fairs in the world – HIMSS24, which will be held March 11-15, 2024 in Orlando, Florida.

MedApp Clinics expands range of services offered – 2023 summary.

In the past year, MedAppClinics has made significant strides in developing and expanding its range of services. A key element of the company’s strategy was the integration with five renowned medical facilities, which strengthened its competence and reach.

CarnaLife Holo with the emblem of Teraz Polska!

We are extremely proud to announce that the CarnaLife Holo by MedApp technology has been awarded the Teraz Polska Emblem in the innovative ventures category.

CarnaLife Holo with FDA (Food and Drugs Administration) certification for the US market!

We are proud to announce that our CarnaLile Holo technology for augmented reality imaging of medical data (interactive holograms) has received 510(k) Class II certification for the world’s largest and richest market for new technology and robotic technology.

MedApp after Q4 2022: continued development of digital medicine technology solutions and acquisition of new sales contacts

As in the previous quarters of 2022, the Company is observing an extension of sales processes in the Polish market, trying to shift sales activity to foreign markets. To this end, the Company has signed further distribution agreements for the CarnaLife Holo solution

We are looking for companies and individuals interested in distributing MedApp’s medical technology.

CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. With the help of Microsoft’s HoloLens 2, the physician can see in real space a three-dimensional hologram reflecting the structure of the imaged anatomical area.

MedApp after Q2 2022: Another Quarter of Geographic and Product Expansion

MedApp, a publicly listed company in the innovative medical technology industry, recorded net sales of PLN 1,588 million, PLN 878 thousand EBITDA earnings and PLN 405 thousand net profit in the second quarter of 2022, despite the increasing uncertainty in the business environment and the challenges facing medical facilities.

MedApp is the laureate of the Special Award of PARP and NCBR

During the Gala of the 24th edition of the Polish Product of the Future competition, we received a special award from the Polish Agency for Enterprise Development and the National Center for Research and Development!

East Value Research Analyst Report – update

An independent analyst report prepared by analysts at East Value Research was released today.

MedApp with record FY 2021 results, doubling revenue and profits from previous year

MedApp reported PLN 12.7 million in net sales revenue cumulatively after four quarters of 2021, 111% higher than a year earlier. EBITDA increased by 139% to PLN 6.3 million, and net profit was twice higher year-on-year, reaching PLN 3.8 million. The company also boasts high profitability.

The tech company MedApp applies to list 209 million shares

“Due to the high volatility of the capital market, we have temporarily suspended the prospectus procedure, but at the same time we want to introduce not yet admitted shares to trading on NewConnect,” says Krzysztof Mędrala, CEO of MedApp S.A.

East Value Research Analyst Report

An independent analyst report prepared by analysts at East Value Research was released today.

MedApp reports record results for 2021, doubling both revenue and profits compared to the previous year

MedApp reported PLN 12.7 million in net sales revenue cumulatively after four quarters of 2021, 111% higher than a year earlier. EBITDA increased by 110% to PLN 5.5 million, and net profit was 94% higher year-on-year, reaching PLN 3.7 million. The company also boasts high profitability.

MedApp in the OVHcloud Startup Program

MedApp, an innovative medtech (SaMD – software as a medical device) company listed in Warsaw and Frankfurt, has joined the OVHcloud Program, Europe’s largest cloud provider supporting startups and scale-ups.

MedApp establishes a company in Germany for the DACH market (Germany, Austria, Switzerland)

This is another important step in our international development. The founding of MedApp Germany GmbH enables us to increase our expansion and shareholder value.

MedApp receives EU funding to proactively support biopsy performance using holographic visualization of imaging data

The agreement with the Polish National Center for Research and Development (NCBiR) is for the project “Intraoperative navigation system based on mixed reality technology to support the precision, comfort and safety of medical procedures”.

CarnaLife Holo used in cardiac ablation procedure in the best hospital in Poland according to World’s Best Hospitals 2021 ranking

The procedure took place at the University Clinical Center (UCK) WUM, at the Clinical Department of Electrocardiology. According to the World’s Best Hospitals 2021 ranking, UCK WUM is the best hospital in Poland.

Development of MedApp SA in 2021

We invite you to summarize the most important events of 2021 in our company.

Mitral valve sealing with MitraClip and CarnaLife Holo

Three-dimensional visualization of imaging diagnostic data of the heart was used in planning and throughout the procedure. As the sterility of the room was not compromised, physicians were able to use the CarnaLife Holo technology unobstructed throughout the procedure and observe the injection sites closely.

Tests of the CarnaLife System application in Medicover Poland yield very good results.

Medicover Polska facilities are testing the CarnaLife System application for remote patient health monitoring. MedApp S.A. software cares for chronically ill patients with diabetes and cardiac problems treated in selected Warsaw facilities of our partner.

Science fiction becomes reality with technologies developed by the publicly traded company MedApp

Using MedApp’s unique CarnaLife Holo technology, we obtained holographic images of the inside of the heart, which we used to perform a minimally invasive mitral valve repair procedure without opening the chest, using the MitraClip system.

Pre-operative surgical planning to remove the liver and pancreatic cancer lesions using CarnaLifeHolo technology!

We invite you to see the video report and hear the doctors’ opinions after the procedure.

East Value Research Analyst Report

An independent analyst report prepared by analysts at East Value Research was released today.

MedApp one of the TOP15 European medtech startups, multiplied revenues and profits

MedApp, a Kraków-based company, recorded close to PLN 3.7 million in revenues between July and September this year, which is almost 4 times more than a year ago. EBITDA in Q3 2021 amounted to PLN 1.6 million (almost 10 times more than last year), and net profit increased by more than PLN 1.4 million (31 times higher yoy).

CarnaLife System will enable remote monitoring of patients of the TeleMed24 Operations and Support Center

With the cooperation established between MedApp S.A. and MKW S.A., the owner of the TeleMed24 brand, patients under the care of the Bytom facility will gain access to full, remote monitoring and diagnostics of heart and circulatory system diseases based on the CarnaLife System platform solutions.

MedApp continues global expansion and launches operations in the Brazilian market

The signed agreement covers the sale of the CarnaLife Holo technology. In the coming week, training sessions for our distributor’s representatives in Brazil are starting. We expect that before the end of the year, the first demonstration treatments using CarnaLife Holo in Brazilian hospitals will be possible.

MedApp S.A., is the partner of the nationwide contest for schoolgirls “Become an Ambassador”.

On October 11, 2021, in celebration of the International Day of the Girl, 12 finalists of the nationwide contest for schoolgirls “Become an Ambassador” were given the opportunity to learn about the world of diplomacy by playing the role of an Ambassador in one of the participating Embassies.

Google selects MedApp S.A. as one of the fifteen best MedTech startups in Europe

Google Accelerator is an initiative of the US giant to support the most promising technology projects. In the current edition, the Google Accelerator has focused on technologies that solve problems in modern medicine, healthcare and improving patient well-being.

MedApp is one of three finalists of the Start-up Challenge 2021 in the category Health and Biotechnology during the European Economic Congress in Katowice

On 21 September 2021, the founders and leaders of the most interesting Polish and European start-ups stood on the stage of the European Economic Congress for the sixth time. Among them, in the category HEALTH & BIOTECHNOLOGY: medicine, health, medical technology, pharmacy, biotechnology was MedApp S.A.

The results generated in H1 2021 by MedApp S.A. are similar to the results the Company achieved for the whole of 2020. The interview with Krzysztof Mędrala, CEO of MedApp S.A.

In connection with the publication of the Interim Report for Q2 2021 on September 12, 2021, we invite you to watch the interview with Krzysztof Mędrala, CEO of MedApp S.A. according to Company’s activities realized in the reporting period and the financial results achieved in H1 2021.

MedApp significantly increases its business scale in Q2 2021.

The Cracow-based company, offering innovative technological solutions in medicine (medtech), achieved a net result in the first half of this year, similar to the level for the whole of last year.

New company address

We are pleased to inform you about the new address. From today, we are available at Armii Krajowej 25, 30-150 Krakow, Poland.

Minority Shareholders of MedApp S.A. obtained representation in the Supervisory Board of the Company

During the Annual General Meeting held on June 29, the Shareholders of MedApp S.A. decided to appoint Mr. Bogusław Bodzioch to the Supervisory Board.

MedApp S.A. in collaboration with Microsoft are extending the functionality of the CarnaLife System platform by making Microsoft Teams available to patients and medical staff

MedApp, the creator of the proprietary CarnaLife System platform for remote diagnosis and monitoring of patients’ health, has expanded cooperation with its existing partner, Microsoft. Access to Microsoft Teams gives patients and physicians using CarnaLife System another convenient and simple tool to communicate during medical consultations.

OPERATION HOLOGRAM – CarnaLife Holo, or technology that will blow your mind!

What can Dr. Maciej Kawecki and Filip Chajzer say about our revolutionary CarnaLife Holo technology for 3D medical data visualization? What does surgery for a rare cancer using a hologram look like? How does the latest technology save lives? How does it work? For the curious, we recommend an episode of “W głowie się nie mieści!” to answer these questions!

MedApp S.A. partnerem profilaktycznej akcji onkologicznej – ONKOODPOWIEDZIALNI

The “Onkoodpowiedzialni” campaign dedicated to oncology education, prevention and health promotion has been launched.

MedAppS.A. strengthens its distribution network in Poland by signing a contract worth nearly EUR 6 million

MedApp, a medtech company that offers solutions based on artificial intelligence, mixed reality, and 3D modeling and imaging, among other things -is strengthening its distribution network.

In connection with the publication of the Interim Report for Q1 2021 on May 14, 2021, we invite you to watch an investor meeting with Krzysztof Mędrala, CEO of MedApp S.A.

The meeting on May 17, 2021 was held by the Polish Association of Individual Investors. We would like to thank Michal Maslowski for the engaging conversation. We appreciate the presence of Investors and Partners interested in our results in the first months of this year and the Company’s plans for the next quarters of 2021. 

MedApp S.A. launches cooperation with Medicover Polska in the area of digital medicine

MedApp, a NewConnect-listed company operating in the medtech segment, has established cooperation with Medicover Poland, a nationwide medical network. As part of the cooperation, the Company will pilot CarnaLife System, digital medicine solution for remote patient health monitoring and treatment management, in selected medical centers.

How is the results of the 1st quarter of 2021 assessed by the Management Board of MedApp S.A.?

MedApp S.A. has achieved very good financial results. We obtained revenues of PLN 1,944,000 and a net result of PLN 376,000. This is another very good quarter in which the Company achieves positive financial results.

MedAppS.A. reports favorable results for the first quarter of 2021

MedApp, a NewConnect-listed company operating in the medtech segmentand offering solutions based on, among others, artificial intelligence, mixed reality and 3D imaging, in the first quarter of 2021 achieved net sales revenues of PLN 1,944,000, which means a continuation of the dynamic growth insales revenues and profits from the end of last year.

MedApp S.A. starts distribution in France

MedApp, a company offering unique software solutions to support diagnostic imaging and new generation digital medicine services, is expanding its presence in Europe by introducing CarnaLife Holo in France and Luxembourg thanks to a distribution agreement with its French partner FP Business SAS.

MedApp recaps 2020. Record financial results and intensive portfolio commercialization

MedApp, a NewConnect-listed technology company whose innovative solutions for diagnostic imaging and digital medicine are revolutionizing the way people are treated, successfully closes out the past year. In 2020, the Company achieved record financial results, reporting an 87-percent increase in revenue and a 185-percent increase in net income over the previous year.

MedApp S.A. participates in Living Lab: a program for developers of innovative digital services and solutions

MedApp, a technology company developing unique solutions to support diagnostic imaging and next-generation digital medicine services, has been selected for NEO Hospital Group’s Living Lab program, which targets developers of innovative digitalservices and solutions.

MedApp to implement StethoMe in its app

MedApp has signed an agreement with StethoMe, a start-up developer of a solution for remote detection of respiratory abnormalities. As part of the partnership, MedApp’s digital medicine application will support a wireless stethoscope. The new device will expand the range of tests offered by medical facilities using CarnaLife System and Digital Clinic solutions.

MedApp’s record results in 2020

MedApp, a NewConnect-listed technology company developing innovative solutions for diagnostic imaging and digital medicine, has released its estimated results for the past year. In 2020, the company’s revenue reached PLN 6,036,000 and increased by 187% compared to 2019 (PLN 3,226,000). In addition, in 2020, MedApp generated a net profit of PLN 2,070,000, an increase of 308% compared to 2019 (PLN 673,000).

MedApp’s record results in 2020

MedApp S.A. starts cooperation with Diagnostyka, a nationwide chain of medical laboratories

MedApp S.A. signed a partnership agreement for a new Digital Clinic service with Diagnostyka, the largest Polish chain of medical laboratories. Thanks to the cooperation, patients and doctors will have easier access to the tests performed by Diagnostyka and secure insight into their results in electronic form -via a computer or a mobile app.

NEO Hospital to use innovative MedApp technologies as part of a research and development project

MedApp S.A. has strengthened its cooperation with NEO Hospital Group. As part of the signed agreement, the Group’s Szpital na Klinach will use the CarnaLife Holo technology for 3D visualization of imaged medical data in the implementation of a newresearch and development project. Its goal is to develop a new method for the surgical treatment of endometrial and cervical cancers.

MedApp enters into an insurance agreement with Chubb European Group SE, beginning expansion into new foreign markets

MedApp has just signed an insurance agreement with Chubb European Group SE, Branch in Poland, for the implementation of activities in thearea of information technology related to healthcare. For the company, which develops innovative 3D holographic imaging technologies, used e.g. in cardiology, oncology and orthopedic procedures (CarnaLife Holo) and in the education of medical staff (SurgeonEye), as well as next-generation digital medicine solutions, this is a major step in expanding into foreign markets.

MedApp expands partnership with Microsoft

MedApp is expanding its partnership with Microsoft. The Company has just obtained Mixed Reality DMP status with the tech giant, making it the official distributor of its mixed reality holographic visualization device, HoloLens 2. MedApp already holds Silver Partner status in the MRPP program and also offers a Microsoft Azure cloud solution to its clients.